Personeni, N.; Pressiani, T.; D’Alessio, A.; Prete, M.G.; Bozzarelli, S.; Terracciano, L.; Dal Buono, A.; Capogreco, A.; Aghemo, A.; Lleo, A.;
et al. Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors. Cancers 2021, 13, 5665.
https://doi.org/10.3390/cancers13225665
AMA Style
Personeni N, Pressiani T, D’Alessio A, Prete MG, Bozzarelli S, Terracciano L, Dal Buono A, Capogreco A, Aghemo A, Lleo A,
et al. Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors. Cancers. 2021; 13(22):5665.
https://doi.org/10.3390/cancers13225665
Chicago/Turabian Style
Personeni, Nicola, Tiziana Pressiani, Antonio D’Alessio, Maria Giuseppina Prete, Silvia Bozzarelli, Luigi Terracciano, Arianna Dal Buono, Antonio Capogreco, Alessio Aghemo, Ana Lleo,
and et al. 2021. "Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors" Cancers 13, no. 22: 5665.
https://doi.org/10.3390/cancers13225665
APA Style
Personeni, N., Pressiani, T., D’Alessio, A., Prete, M. G., Bozzarelli, S., Terracciano, L., Dal Buono, A., Capogreco, A., Aghemo, A., Lleo, A., Lutman, R. F., Roncalli, M., Giordano, L., Santoro, A., Di Tommaso, L., & Rimassa, L.
(2021). Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors. Cancers, 13(22), 5665.
https://doi.org/10.3390/cancers13225665
